U.MIR PHARMA LTD

Company Registration Number:
07321929 (England and Wales)

Unaudited abridged accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 August 2023

End date: 31 July 2024

U.MIR PHARMA LTD

Contents of the Financial Statements

for the Period Ended 31 July 2024

Balance sheet
Notes

U.MIR PHARMA LTD

Balance sheet

As at 31 July 2024


Notes

2024

2023


£

£
Fixed assets
Intangible assets: 3 14,015 17,779
Tangible assets: 4 164,686 198,914
Investments: 5 167,500 0
Total fixed assets: 346,201 216,693
Current assets
Stocks: 71,000 85,000
Debtors: 6 198,010 228,664
Cash at bank and in hand: 71,135 7,546
Total current assets: 340,145 321,210
Creditors: amounts falling due within one year:   (317,075) (274,617)
Net current assets (liabilities): 23,070 46,593
Total assets less current liabilities: 369,271 263,286
Creditors: amounts falling due after more than one year:   (202,231) (159,016)
Total net assets (liabilities): 167,040 104,270
Capital and reserves
Called up share capital: 2,002 2,002
Profit and loss account: 165,038 102,268
Shareholders funds: 167,040 104,270

The notes form part of these financial statements

U.MIR PHARMA LTD

Balance sheet statements

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 17 April 2025
and signed on behalf of the board by:

Name: Usman Mir
Status: Director

The notes form part of these financial statements

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

2. Employees

2024 2023
Average number of employees during the period 18 13

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

3. Intangible Assets

Total
Cost £
At 01 August 2023 37,635
At 31 July 2024 37,635
Amortisation
At 01 August 2023 19,856
Charge for year 3,764
At 31 July 2024 23,620
Net book value
At 31 July 2024 14,015
At 31 July 2023 17,779

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

4. Tangible Assets

Total
Cost £
At 01 August 2023 354,630
At 31 July 2024 354,630
Depreciation
At 01 August 2023 155,716
Charge for year 34,228
At 31 July 2024 189,944
Net book value
At 31 July 2024 164,686
At 31 July 2023 198,914

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

5. Fixed investments

Investments are included in the balance sheet at cost less any provision for impairment. The Company assess investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. If such an indication of impairment exists, the Company makes an estimate of the recoverable amount of the investment. If the recoverable amount is less than the value of the investment, the investment is written down to the recoverable amount. An impairment loss is recognised immediately in the profit and loss account. If the impairment is not considered to be a permanent diminution in value it may reverse in a future period to the extent that it is no longer considered necessary.

U.MIR PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

6. Debtors

2024 2023
££
Debtors due after more than one year: 198,010 228,664